Phaseline

Targets › TNFRSF8

TNFRSF8 (Tumor necrosis factor receptor superfamily member 8): drug programs, companies and trials

3 programs from 2 companies in 38 trials: 27 Phase 2, 6 Phase 1, 4 Phase 3, 1 Phase 4; Oncology, Hematology; next expected readout Mar 2027.

Receptor for TNFSF8/CD30L. May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF-kappa-B. (UniProt, P28908)

Open in Phaseline: the race on TNFRSF8, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
TakedaBrentuximab Vedotin
Tubulin inhibitor; Tumor necrosis factor receptor superfamily member 8 binding agent
Tubulin, TNFRSF8Phase 4Hodgkin Lymphoma; Lymphoma; Hodgkin Disease; Ann Arbor Stage III Hodgkin Lymphoma …Dec 2027
City of Hope Medical CenterActinium Ac 225-DOTA-Daratumumab
Anti-CD38 monoclonal antibody conjugated to actinium-225, delivering targeted alpha radiat
TNFRSF8Phase 1Recurrent Plasma Cell MyelomaMar 2027
City of Hope Medical CenterIndium In 111-DOTA-Daratumumab
Anti-CD38 monoclonal antibody conjugated to indium-111, delivering targeted gamma radiatio
TNFRSF8Phase 1Recurrent Plasma Cell MyelomaMar 2027

Conditions

Hodgkin Lymphoma (7) Lymphoma (2) Mycosis Fungoides (2) Ann Arbor Stage I Hodgkin Lymphoma (2) Classical Hodgkin Lymphoma (2) Recurrent Classic Hodgkin Lymphoma (2) Recurrent Plasma Cell Myeloma (2) Hodgkin Disease (1) Ann Arbor Stage III Hodgkin Lymphoma (1) Ann Arbor Stage IIB Hodgkin Lymphoma (1) Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8 (1) Ann Arbor Stage IB Hodgkin Lymphoma (1)

Modalities

antibody (2), mixed (1)

Companies

City of Hope Medical Center (2) Takeda (1)

Related targets

Tubulin (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.